Literature DB >> 34693283

Voluntary Pregnancy Screening at Syringe Exchanges: A Feasibility Study.

Camille C Cioffi1, John R Seeley1.   

Abstract

The purpose of this study was to explore the feasibility of offering voluntary pregnancy screening at syringe exchange programs using the National Implementation Research Network Hexagon Discussion and Analysis Tool. We conducted a survey among female syringe exchange clients that assessed perceived needs, values, and behavioral intentions for parenting and entering treatment if they received a positive pregnancy screen and surveys among staff and core volunteers to assess organizational fit, capacity, and needed supports. Participants and staff reported that pregnancy screening was needed at syringe exchange and that capacity needs to be expanded to provide services. Pregnancy screening at syringe exchanges holds the potential to lead to early detection of pregnancy. Early detection of pregnancy among women who inject drugs may result in improved prenatal care, including substance use treatment and treatment of infectious diseases, for women who would otherwise be unlikely to receive prenatal care.

Entities:  

Keywords:  Syringe exchange; implementation science; injection drug; pregnancy screening

Year:  2021        PMID: 34693283      PMCID: PMC8528196          DOI: 10.1177/2632077020973362

Source DB:  PubMed          Journal:  J Prev Health Promot        ISSN: 2632-0770


  35 in total

1.  Syringe Service Programs for Persons Who Inject Drugs in Urban, Suburban, and Rural Areas - United States, 2013.

Authors:  Don C Des Jarlais; Ann Nugent; Alisa Solberg; Jonathan Feelemyer; Jonathan Mermin; Deborah Holtzman
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-12-11       Impact factor: 17.586

2.  Screening for HIV Infection in Pregnant Women: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.

Authors:  Shelley S Selph; Christina Bougatsos; Tracy Dana; Sara Grusing; Roger Chou
Journal:  JAMA       Date:  2019-06-18       Impact factor: 56.272

3.  Neonatal drug withdrawal.

Authors:  Mark L Hudak; Rosemarie C Tan
Journal:  Pediatrics       Date:  2012-01-30       Impact factor: 7.124

4.  Methamphetamines and pregnancy outcomes.

Authors:  Tricia E Wright; Renee Schuetter; Jacqueline Tellei; Lynnae Sauvage
Journal:  J Addict Med       Date:  2015 Mar-Apr       Impact factor: 3.702

5.  One Key Question®: First Things First in Reproductive Health.

Authors:  Deborah Allen; Michele Stranger Hunter; Susan Wood; Tishra Beeson
Journal:  Matern Child Health J       Date:  2017-03

6.  Menstrual cycle length during methadone maintenance.

Authors:  John Schmittner; Jennifer R Schroeder; David H Epstein; Kenzie L Preston
Journal:  Addiction       Date:  2005-06       Impact factor: 6.526

Review 7.  Postpartum substance use and depressive symptoms: a review.

Authors:  Shawna L Carroll Chapman; Li-Tzy Wu
Journal:  Women Health       Date:  2013

8.  Characteristics of women who deliver with no prenatal care.

Authors:  R Maupin; R Lyman; J Fatsis; E Prystowiski; A Nguyen; C Wright; P Kissinger; J Miller
Journal:  J Matern Fetal Neonatal Med       Date:  2004-07

9.  Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.

Authors:  E M Connor; R S Sperling; R Gelber; P Kiselev; G Scott; M J O'Sullivan; R VanDyke; M Bey; W Shearer; R L Jacobson
Journal:  N Engl J Med       Date:  1994-11-03       Impact factor: 91.245

10.  Association between Pregnancy and Active Injection Drug Use and Sex Work among Women Injection Drug Users in Saint Petersburg, Russia.

Authors:  P Girchenko; D C Ompad; D Bikmukhametov; L Gensburg
Journal:  J Urban Health       Date:  2015-06       Impact factor: 3.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.